NCT06591247 Membrane Stripping for Cervical Ripening
| NCT ID | NCT06591247 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Meir Medical Center |
| Condition | Labor, Induced |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-08-07 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2024-08-07 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this interventional study is to evaluate the effectiveness of membrane stripping in cervical ripening compared to double balloon catheter induction. The study population consists of women undergoing labor induction. The main questions it aims to answer are: 1. Is membrane stripping as effective as double balloon catheter induction in cervical ripening? 2. What is the influence of membrane stripping on the time required for cervical ripening, delivery duration, and maternal and fetal outcomes compared to balloon induction.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 and above * Patients with a cervical dilation of at least 1 cm * Full-term pregnancy * Cephalic presentation * No contraindication to vaginal delivery Exclusion Criteria: * Patients with rupture of membranes * Patients who do not require cervical ripening and proceed directly to the delivery room for induction with oxytocin * Patients for whom the use of a double-balloon catheter/PGE2 is contraindicated * Twin pregnancies * Pregnancies with macrosomic fetuses where vaginal delivery is contraindicated * Patients with maternal or fetal pathologies that do not allow for vaginal delivery due to concerns about fetal or maternal distress
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06591247 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Labor, Induced. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06591247 currently recruiting?
Yes, NCT06591247 is actively recruiting participants. Contact the research team at galcwork@gmail.com for enrollment information.
Where is the NCT06591247 trial being conducted?
This trial is being conducted at Kfar Saba, Israel.
Who is sponsoring the NCT06591247 clinical trial?
NCT06591247 is sponsored by Meir Medical Center. The trial plans to enroll 400 participants.